Mabvinra Adalimumab Prefilled Glass Syringe 40 mg

AboutMabvinra is a single-use prefilled glass syringe containing Adalimumab 40 mg. It is a prescription biologic used for selected autoimmune and inflammatory conditions, including rheumatoid arthritis, psoriasis, ankylosing spondylitis, Crohn’s disease and ulcerative colitis.Usage InstructionsFor subcutaneous use only. Administer according to the specialist’s instructions after receiving training. Do not inject into tender, bruised, red, hard or scarred skin. Do not share or reuse the syringe.BenefitsMay reduce inflammation, pain, swelling and disease activity in approved autoimmune conditions.How it WorksAdalimumab is a tumour necrosis factor inhibitor. It binds to TNF-alpha and reduces inflammatory signalling.Side EffectsInjection-site reactions, headache, upper respiratory symptoms and infections may occur. Serious risks include severe infection, tuberculosis, hepatitis B reactivation, demyelinating disease, heart failure worsening and certain malignancies.Safety AdvicePrescription use only. Screening for tuberculosis and hepatitis B may be required before treatment. Avoid live vaccines unless specifically approved. Tell the doctor about infection, fever, recurrent illness, neurological disease, heart failure, pregnancy, breastfeeding and all medicines. Seek urgent help for severe infection or allergy.StorageStore refrigerated at 2°C to 8°C. Do not freeze or shake. Protect from light and keep in the original carton. Follow the approved room-temperature allowance on the product label during transport or use.